{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T17:50:03Z","timestamp":1758477003437},"reference-count":47,"publisher":"Georg Thieme Verlag KG","issue":"06","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Thromb Haemost"],"published-print":{"date-parts":[[2014]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>Chronic hepatitis C is the main cause of morbidity and mortality in adult haemophilic patients who received non-virally inactivated plasma-derived clotting factor concentrates. Overall, spontaneous viral clearance rate is 10\u201325% and the only approach that can halt disease progression is hepatitis C virus (HCV) eradication by means of antiviral therapy. In non-haemophilic patients a single nucleotide polymorphism located upstream the gene of interferon lambda 3 (IFN\u03bb3) has been associated with both spontaneous viral clearance and sustained virological response after antiviral treatment. The aim of this study was to assess whether the rs12979860 polymorphism was a predictor of spontaneous viral clearance and of sustained virological response after antiviral therapy in a large cohort of haemophilic patients with HCV infection. The rs12979860 polymorphism, defined as CC genotype or T allele, was tested in a cohort of 342 haemophilic patients and evaluated as predictor of spontaneous clearance or response to antiviral therapy. By multivariate regression analysis the IFN\u03bb3 CC genotype was an independent predictor of spontaneous viral clearance (odds ratio: 3.7, 95% confidence interval: 2.0\u20136.8). Sustained virological response rates were doubled in patients with the CC genotype than in those with the T allele (78% vs 44%; p&lt;0.001), especially in patients with HCV type 1 (67% vs 32%; p&lt;0.001) and higher sustained response rates were observed in patients with the CC genotype who did not achieve rapid virological response (61% vs 30% in T allele patients; p=0.006).<\/jats:p>","DOI":"10.1160\/th13-11-897","type":"journal-article","created":{"date-parts":[[2014,2,13]],"date-time":"2014-02-13T10:28:25Z","timestamp":1392287305000},"page":"1067-1076","source":"Crossref","is-referenced-by-count":6,"title":["Interferon lambda 3 rs12979860 polymorphism in patients with haemophilia and HCV infection: a predictor of spontaneous viral clearance and sustained virological response"],"prefix":"10.1160","volume":"111","author":[{"given":"Silvia","family":"Linari","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessio","family":"Aghemo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dario","family":"Bartolozzi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Santagostino","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Grazia","family":"Rumi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisa","family":"Fognani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Rosaria","family":"Fasulo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Gragnani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raffaele","family":"Bruno","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Massimo","family":"Morfini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna Linda","family":"Zignego","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Massimo","family":"Colombo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Elisa","family":"Mancuso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"194","published-online":{"date-parts":[[2017,11,21]]},"reference":[{"key":"ref1","first-page":"602","article-title":"Natural history of hepatitis C infection in multitransfused haemophiliacs: effect of coinfection with human immunodeficiency virus","volume":"06","author":"ME Eyster","year":"1993","journal-title":"JAIDS"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1093\/aje\/kwm030","article-title":"Reconstruction of the hepatitis C virus epidemic in the US haemophilia population, 1940-1990","volume":"165","author":"JJ Goedert","year":"2007","journal-title":"Am J Epidemiol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1053\/j.gastro.2006.07.001","article-title":"Haemophilic siblings with chronic hepatitis C: Familial aggregation of spontaneous and treatment-related viral clearance","volume":"131","author":"MW Fried","year":"2006","journal-title":"Gastroenterology"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1053\/he.2000.5762","article-title":"Natural history of hepatitis C: its impact on clinical management","volume":"31","author":"AM Di Bisceglie","year":"2000","journal-title":"Hepatology"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/j.1365-2893.2005.00651.x","article-title":"Spontaneous viral clearance following acute hepatitis C infection: a systematic review of longitudinal studies","volume":"13","author":"JM Micallef","year":"2006","journal-title":"J Viral Hepat"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1155\/2007\/796325","article-title":"Factors associated with spontaneous clearance of hepatitis C virus among illicit drug users","volume":"21","author":"J Grebely","year":"2007","journal-title":"Can J Gastroeneterol"},{"key":"ref7","first-page":"80","article-title":"Acute hepatitis C: high rate of both spontaneous and treatment induced viral clearance","volume":"125","author":"JT Gerlach","year":"2003","journal-title":"Gastroenterology"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1056\/NEJM199909163411202","article-title":"Prevalence and clinical outcome of hepatitis C infection in children who underwent cardiac surgery before the implementation of blood-donor screening","volume":"341","author":"M Vogt","year":"1999","journal-title":"N Engl J Med"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1056\/NEJM199904223401602","article-title":"Clinical outcomes after hepatitis C infection from contaminated anti-D immune globulin. Irish Hepatology Research Group","volume":"340","author":"E Kenny-Walsh","year":"1999","journal-title":"N Engl J Med"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"379","DOI":"10.7326\/0003-4819-112-5-379","article-title":"High prevalence of antibody to hepatitis C virus in multitransfused haemophiliacs with normal transaminase levels","volume":"112","author":"MG Rumi","year":"1990","journal-title":"Ann Intern Med"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1182\/blood.V76.1.254.254","article-title":"Prevalence of hepatitis C virus antibody in a cohort of haemophilia patients","volume":"76","author":"DB Brettler","year":"1990","journal-title":"Blood"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1182\/blood-2006-10-050435","article-title":"Mortality rates, life expectancy, and causes of death in people with haemophilia A or B in the United Kingdom who were not infected with HIV","volume":"110","author":"SC Darby","year":"2007","journal-title":"Blood"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1182\/blood-2005-11-4407","article-title":"Mortality rates and causes of death among all HIV-positive individuals with haemophilia in Canada over 21 yers of follow-up","volume":"108","author":"DM Arnold","year":"2006","journal-title":"Blood"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"3667","DOI":"10.1182\/blood-2006-08-038349","article-title":"Progression to end-stage liver disease in patients with inherited bleeding disorders and hepatitis C: an international, multicenter cohort study","volume":"109","author":"D Posthouwer","year":"2007","journal-title":"Blood"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1111\/j.1365-2516.2005.01138.x","article-title":"Prevalence of conditions associated with human immunodeficiency and hepatits virus infections among persons with haemophilia, 2001-2003","volume":"11","author":"Goedert JJ for the Second Multicenter Haemophilia Cohort Study","year":"2005","journal-title":"Haemophilia"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.cgh.2011.03.004","article-title":"A sustained virologic response reduces risk of all-cause mortality in patients with hepatitis C","volume":"09","author":"LI Backus","year":"2011","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref17","first-page":"2","article-title":"2011 European Association of the Study of the Liver hepatitis C virus clinical practice guidelines","volume":"32","author":"European Association of the Study of the Liver","year":"2012","journal-title":"iver Int"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/ajg.2012.48","article-title":"Update on the management and treatment of hepatitis C virus infection: recommendations from the Department of Veterans Affairs Hepatitis C Resource Center Program and the National Hepatitis C Program Office","volume":"107","author":"HS Yee","year":"2012","journal-title":"Am J Gastroenterol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/S0140-6736(01)06102-5","article-title":"Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial","volume":"358","author":"MP Manns","year":"2001","journal-title":"Lancet"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1056\/NEJMoa020047","article-title":"Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection","volume":"347","author":"MW Fried","year":"2002","journal-title":"N Engl J Med"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"346","DOI":"10.7326\/0003-4819-140-5-200403020-00010","article-title":"Peginterferon-\u03b12a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose","volume":"140","author":"SJ Hadziyannis","year":"2004","journal-title":"Ann Intern Med"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1056\/NEJMoa0808010","article-title":"Peginterferon alfa-2b or alfa-2a with ribavirin for treatment of hepatitis C infection","volume":"361","author":"JG McHutchison","year":"2009","journal-title":"N Engl J Med"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1056\/NEJMoa032502","article-title":"Peginterferon alfa-2b and ribavirin for the treatment of chronic hepatitis C in blacks and non-Hispanic whites","volume":"350","author":"AJ Muir","year":"2004","journal-title":"N Engl J Med"},{"key":"ref24","first-page":"1367","article-title":"High efficacy of combined therapy with pegylated interferon plus ribavirin in patients with haemophilia and chronic hepatitis C","volume":"91","author":"ME Mancuso","year":"2006","journal-title":"Haematologica"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1111\/j.1538-7836.2009.03624.x","article-title":"Hepatitis C virus\/human immunodeficiency virus coinfection in haemophiliacs: high rates of sustained virologic response to pegylated interferon and ribavirin therapy","volume":"07","author":"ME Mancuso","year":"2009","journal-title":"J Thromb Haemost"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1111\/j.1538-7836.2007.02619.x","article-title":"Antiviral therapy for chronic hepatitis C in patients with inherited bleeding disorders: an international, multicenter cohort study","volume":"05","author":"D Posthouwer","year":"2007","journal-title":"J Thromb Haemost"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1111\/j.1365-2516.2009.01972.x","article-title":"HCV treatment with pegylated interferon and ribavirin in patients with haemophilia and HIV\/HCV co-infection","volume":"15","author":"JT Denholm","year":"2009","journal-title":"Haemophilia"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1038\/nature08463","article-title":"Genetic variation in IL28B and spontaneous clearance of hepatitis C virus","volume":"461","author":"DL Thomas","year":"2009","journal-title":"Nature"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/nature08309","article-title":"Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance","volume":"461","author":"D Ge","year":"2009","journal-title":"Nature"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1053\/j.gastro.2010.04.013","article-title":"Interleukin-28B polymorphism improves viral kinetics and is the strongest pretreatment predictor of sustained virologic response in genotype 1 hepatitis C virus","volume":"139","author":"AJ Thompson","year":"2010","journal-title":"Gastroenterology"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"3851","DOI":"10.1128\/JVI.79.6.3851-3854.2005","article-title":"Lambda interferon inhibits hepatitis B and C virus replication","volume":"79","author":"MD Robek","year":"2005","journal-title":"J Virol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1053\/j.gastro.2006.09.052","article-title":"Interferons alpha and lambda inhibit hepatitis C virus replication with distinct signal transduction and gene regulation kinetics","volume":"131","author":"T Marcello","year":"2006","journal-title":"Gastroenterology"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jhep.2008.08.018","article-title":"Early detection in routine clinical practice of cirrhosis and oesophageal varices in chronic hepatitis C: comparison of transient elastography (FibroScan) with standard laboratory tests and non-invasive scores","volume":"50","author":"L Cast\u00e9ra","year":"2009","journal-title":"J Hepatol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1111\/j.1365-2893.2010.01349.x","article-title":"A tetra-primer amplification refractory mutation system polymerase chain reaction for the evaluation of rs12979860 IL28B genotype","volume":"18","author":"E Galmozzi","year":"2011","journal-title":"J Viral Hepat"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"e325","DOI":"10.1111\/j.1365-2893.2010.01425.x","article-title":"IL28B polymorphisms determine early viral kinetics and treatment outcome in patients receiving peginterferon\/ribavirin for chronic hepatitis C genotype 1","volume":"18","author":"M Lindh","year":"2011","journal-title":"J Viral Hepat"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1002\/hep.24546","article-title":"Impact of IL28B on treatment outcome in hepatitis C virus G1\/4 patients receiving response-guided therapy with Peginterferon alpha-2a (40KD)\/ribavirin","volume":"54","author":"TM Scherzer","year":"2011","journal-title":"Hepatology"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.jhep.2011.10.004","article-title":"Single nucleotide polymorphism upstream of interleukin 28B associated with phase 1 and phase 2 of early viral kinetics in patients infected with HCV genotype 1","volume":"56","author":"CD Howell","year":"2012","journal-title":"J Hepatol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1053\/j.gastro.2009.12.056","article-title":"Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study","volume":"138","author":"A Rauch","year":"2010","journal-title":"Gastroenterology"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1182\/blood-2005-07-2781","article-title":"Correlates of spontaneous clearance of hepatitis C virus among people with haemophilia","volume":"107","author":"M Zhang","year":"2006","journal-title":"Blood"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1111\/j.1365-2141.1993.tb03356.x","article-title":"Interaction of hepatitis B and hepatitis C infection in haemophilia","volume":"85","author":"JP Hanley","year":"1993","journal-title":"Br J Haematol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1007\/s10875-011-9547-1","article-title":"Role of interleukin 28B rs12979860 C\/T polymorphism on the histological out come of chronic hepatitis C: relationship with gender and viral genotype","volume":"31","author":"E Falleti","year":"2011","journal-title":"J Clin Immunol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.jhep.2010.07.019","article-title":"IL-28B rs12979860 C\/T allele distribution in patients with liver cirrhosis: role in the course of chronic viral hepatitis and the development of HCC","volume":"54","author":"C Fabris","year":"2011","journal-title":"J Hepatol"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1002\/hep.24503","article-title":"Genetic variation in the interleukin-28B gene is not associated with fibrosis progression in patients with chronic hepatitis C and known date of infection","volume":"54","author":"F Marabita","year":"2011","journal-title":"Hepatology"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.jhep.2010.07.041","article-title":"Importance of IL28B gene polymorphisms in hepatitis C virus genotype 2 and 3 infected patients","volume":"54","author":"C Sarrazin","year":"2011","journal-title":"J Hepatol"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"679","DOI":"10.3324\/haematol.2011.050351","article-title":"IL28B polymorphisms influence stage of fibrosis and spontaneous or interferon-induced viral clearance in thalassemia patients with hepatitis C virus infection","volume":"97","author":"V Di Marco","year":"2012","journal-title":"Haematologica"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/j.1468-1293.2011.00912.x","article-title":"Different distributions of hepatitis C virus genotypes among HIV-infected patients with acute and chronic hepatitis C according to interleukin-28B genotype","volume":"12","author":"K Neukam","year":"2011","journal-title":"HIV Medicine"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1002\/hep.26371","article-title":"New horizons in hepatitis C antiviral therapy with direct-acting antivirals","volume":"58","author":"A Aghaemo","year":"2013","journal-title":"Hepatology"}],"container-title":["Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1160\/TH13-11-897.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,31]],"date-time":"2023-05-31T12:09:13Z","timestamp":1685534953000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1160\/TH13-11-897"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014]]},"references-count":47,"journal-issue":{"issue":"06","published-online":{"date-parts":[[2017,11,17]]},"published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1160\/th13-11-897","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0340-6245","2567-689X"],"issn-type":[{"value":"0340-6245","type":"print"},{"value":"2567-689X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014]]}}}